Top-Rated StocksTop-RatedNASDAQ:BBIO BridgeBio Pharma (BBIO) Insider Trading & Ownership $27.73 -0.41 (-1.46%) (As of 09/20/2023 ET) Add Compare Share Share Today's Range$27.54▼$28.4350-Day Range$17.31▼$35.0152-Week Range$6.64▼$36.36Volume1.22 million shsAverage Volume2.72 million shsMarket Capitalization$4.51 billionP/E RatioN/ADividend YieldN/APrice Target$37.30 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability BridgeBio Pharma (NASDAQ:BBIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.52%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$65.09 M Get BBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling BridgeBio Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BBIO Insider Buying and Selling by Quarter BridgeBio Pharma Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails8/17/2023Brian C StephensonCFOSell22,683$28.59$648,506.9736,710 8/17/2023Neil KumarCEOSell51,552$28.59$1,473,871.684,813,197 7/18/2023Global Investors Lp VikingMajor ShareholderSell1,500,000$35.00$52,500,000.0025,120,991 5/17/2023Brian C StephensonCFOSell24,424$14.01$342,180.2436,408 5/17/2023Neil KumarCEOSell51,552$14.01$722,243.524,813,197 4/5/2023Brian C StephensonCFOSell55,500$15.45$857,475.00101,337 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/5/2023Neil KumarCEOSell120,000$15.46$1,855,200.001,132,722 3/3/2023Brian C StephensonCFOSell62,692$10.96$687,104.32156,837 3/3/2023Neil KumarCEOSell120,000$10.96$1,315,200.001,252,722 2/17/2023Brian C StephensonCFOSell17,717$12.70$225,005.90219,529 2/17/2023Neil KumarCEOSell44,798$12.70$568,934.604,813,197 2/3/2023Brian C StephensonCFOSell61,040$11.01$672,050.40219,184 2/3/2023Neil KumarCEOSell120,000$11.01$1,321,200.001,372,722 1/5/2023Brian C StephensonCFOSell61,040$7.67$468,176.80280,224 1/5/2023Neil KumarCEOSell120,000$7.67$920,400.001,492,722 11/17/2022Brian C StephensonCFOSell19,678$9.40$184,973.20341,264 11/17/2022Neil KumarCEOSell34,640$9.40$325,616.004,813,197 (Data available from 1/1/2013 forward) BBIO Insider Trading Activity - Frequently Asked Questions Who is on BridgeBio Pharma's Insider Roster? The list of insiders at BridgeBio Pharma includes Brian C Stephenson, Cameron Turtle, Charles J Homcy, Douglas A Dachille, Genetic Disorder L.P. Kkr, Global Investors Lp Viking, Michael Thomas Henderson, Neil Kumar, Randal W Scott, Richard H Scheller, and Ronald J Daniels. Learn more on insiders at BBIO. What percentage of BridgeBio Pharma stock is owned by insiders? 28.52% of BridgeBio Pharma stock is owned by insiders. Learn more on BBIO's insider holdings. Which BridgeBio Pharma insiders have been buying company stock? The following insiders have purchased BBIO shares in the last 24 months: Douglas A Dachille ($166,000.00), and Ronald J Daniels ($298,678.53). How much insider buying is happening at BridgeBio Pharma? Insiders have purchased a total of 37,147 BBIO shares in the last 24 months for a total of $464,678.53 bought. Which BridgeBio Pharma insiders have been selling company stock? The following insiders have sold BBIO shares in the last 24 months: Brian C Stephenson ($4,085,472.83), Global Investors Lp Viking ($52,500,000.00), and Neil Kumar ($8,502,665.80). How much insider selling is happening at BridgeBio Pharma? Insiders have sold a total of 2,487,316 BridgeBio Pharma shares in the last 24 months for a total of $65,088,138.63 sold. More Insider Trading Tools from MarketBeat Related Companies: Vaxcyte Insider Selling Nuvalent Insider Selling DICE Therapeutics Insider Selling Exelixis Insider Selling IDEAYA Biosciences Insider Selling Amylyx Pharmaceuticals Insider Selling 89bio Insider Selling Acelyrin Insider Selling Mirum Pharmaceuticals Insider Selling Verona Pharma Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Institutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying 3 Stocks to Buy After Heavy Insider Buying This page (NASDAQ:BBIO) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.